Treatment options for end stage renal disease

Primary Care
Paul W Crawford, Edgar V Lerma

Abstract

The latest National Health and Nutrition Study revealed an increasing incidence of kidney disease among aging baby boomers, as the incidence of diabetes mellitus and hypertension rises. Because of this trend, a greater proportion of a primary care physician's practice will involve patients with chronic kidney disease, and consequently, end stage renal disease. Unfortunately, far too many of these chronic kidney disease patients are referred to a nephrologist very late. More often than not, the opportunity for secondary preventive intervention, with the goal of avoiding renal replacement therapy, is lost. This article addresses the various treatment options for patients with end stage renal disease.

References

Aug 1, 1992·Diabetes Care·S F WetterhallF Vinicor
Nov 1, 1993·Journal of the American Society of Nephrology : JASN·R H SadowskiK Jabs
Aug 1, 1996·Kidney International·W E BloembergenP J Held
Oct 17, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J L HolleyO Bronsther
Mar 10, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M RahmanM C Smith
Sep 6, 2000·Kidney International·H U Meier-KriescheB Kaplan
Oct 14, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A Levin
Mar 27, 2001·Transplantation Proceedings·H Meier-KriescheB Kaplan
Apr 19, 2002·Journal of the American Society of Nephrology : JASN·Bertram L KasiskeAnnamaria T Kausz
Sep 24, 2004·Transplantation·John S GillBrian J G Pereira
Jul 3, 2007·Advances in Chronic Kidney Disease·Bernard G JaarJosef Coresh

❮ Previous
Next ❯

Citations

May 23, 2009·Transplantation Proceedings·S VaccarisiB Nardo
Dec 21, 2011·Journal of Periodontal Research·F BritoR G Fischer
Jun 28, 2016·Pharmacology & Therapeutics·Alan R Parrish

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Richard S Mangus, Brian W Haag
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Alan CassJohn Z Ayanian
Kidney International. Supplement
Moses D Wavamunno, David C H Harris
© 2022 Meta ULC. All rights reserved